Sebacia, Inc. entered into a sale purchase agreement to all acquire assets of Sienna Biopharmaceuticals, Inc. (OTCPK:SNNA.Q) for $1.7 million on December 5, 2019. Sebacia shall pay in cash $1.7 million and shall assume the assumed liabilities by executing the assumption agreement. The transaction is subject to approval of Bankruptcy Court. Brian Cuneo and Ted Dillman of Latham & Watkins LLP acted as legal advisor to Sienna. David Wood and Matthew Grimshaw of Marshack Hays LLP acted as legal advisor to Sebacia in the transaction.